EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Human Platelet Lysate Treatment for Exposure Keratopathy: An In Vivo Confocal Microscopy and Anterior Segment OCT Study

Chia-Ying Tsai, Wei-Lun Huang, Shang-Chih Yang, Bo-Da Huang, Vladlen Klochkov, Shu-Lang Liao, Albert Y Wu, Wei-Li Chen

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.6.73 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Chia-Ying Tsai and 7 co-authors. Institution: Department of Ophthalmology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan. Major MEDLINE topics: Blood Platelets, Corneal Diseases, Anterior Eye Segment. Cited 2 times so far (Crossref); 61 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Purpose

To investigate the effects of topical human platelet lysate (HPL) on exposure keratopathy (EK) in a rabbit model, with a focus on its anti-inflammatory and anti-dehydration properties on the cornea.

Methods

Short-term exposure keratopathy was induced in New Zealand albino rabbits by keeping the eyelids open for four hours, followed by eyelid closure for another four hours, during which the treatment was applied. HPL, fetal bovine serum (FBS), or preservative-free artificial tears (PFAT) were administered every 15 minutes, and corticosteroid was applied every one hour during the treatment period. Corneal thickness changes and epithelial defects were assessed using anterior segment optical coherence tomography (AS-OCT) and fluorescein staining. In vivo confocal microscopy (IVCM) was used to evaluate inflammatory cell infiltration, whereas immunohistochemistry (IHC) was performed to confirm the presence of CD8+ T cells, neutrophils, and macrophages and the cell proliferation marker Ki67.

Results

After completing the treatment, no significant difference in fluorescein staining was observed among the four groups. However, AS-OCT revealed more effective recovery of corneal thinning in the HPL- and FBS-treated groups, including improvements in epithelial, stromal, and total corneal thickness. IVCM revealed significantly reduced infiltration of inflammatory cells in the HPL-, FBS-, and corticosteroid-treated groups compared to the PFAT-treated group across the central cornea, peripheral cornea, and conjunctiva. IHC for CD8+ T cells, neutrophils, and macrophages showed similar findings. HPL-treated groups showed more Ki-67-positive cells compared to the PFAT- and corticosteroid-treated groups.

Conclusions

HPL treatment effectively reduced inflammation, promoted the recovery of corneal thickness, and induced cellular proliferation after dehydration, demonstrating its potential as a treatment for EK.

Subjects

MeSH terms (MEDLINE)

Blood PlateletsCorneal DiseasesAnterior Eye SegmentAnimalsTomography, Optical CoherenceRabbitsMicroscopy, ConfocalDisease Models, AnimalHumansCornea

Authors and institutions

  • Department of Ophthalmology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan.
  • School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
  • Graduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City, Taiwan.
  • Graduate Institute of Clinical Medicine, National Taiwan University, College of Medicine, Taipei, Taiwan.
  • Department of Ophthalmology, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan.
  • Department of Ophthalmology, National Taiwan University College of Medicine, Taipei, Taiwan.

Cite

APA

Tsai, C. Y., Huang, W. L., Yang, S. C., Huang, B. D., Klochkov, V., Liao, S. L., Wu, A. Y., & Chen, W. L. (2025). Human Platelet Lysate Treatment for Exposure Keratopathy: An In Vivo Confocal Microscopy and Anterior Segment OCT Study. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.6.73

Vancouver

Tsai CY, Huang WL, Yang SC, Huang BD, Klochkov V, Liao SL, et al. Human Platelet Lysate Treatment for Exposure Keratopathy: An In Vivo Confocal Microscopy and Anterior Segment OCT Study. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.6.73

BibTeX
@article{Tsai2025,
  author = {Tsai, Chia-Ying and Huang, Wei-Lun and Yang, Shang-Chih and Huang, Bo-Da and Klochkov, Vladlen and Liao, Shu-Lang and Wu, Albert Y and Chen, Wei-Li},
  title = {Human Platelet Lysate Treatment for Exposure Keratopathy: An In Vivo Confocal Microscopy and Anterior Segment OCT Study},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.6.73}
}
Start for free →